Next-generation sequencing (NGS) is revolutionizing oncology through the rapid, high-throughput interrogation of genetic material that allows for accurate cancer diagnosis, prognosis, and treatment planning. The "NextGen Sequencing" session highlights the uses, advantages, and developments of NGS in contemporary cancer treatment.".
NGS enables in-depth profiling of tumor genomes, detecting mutations, gene fusions, copy number variation, and other molecular changes that fuel cancer growth. The data informs personalized therapy, enabling clinicians to prescribe targeted treatments, immunotherapies, or combination approaches based on individual patients' profiles. NGS is similarly invaluable in monitoring disease progression, recognizing minimal residual disease, and identifying developing resistance mutations.
The session delves into real-world applications in solid tumors, hematologic malignancies, and rare cancers, and technological advances that enhance accuracy, sensitivity, and turnaround time. Bioinformatics and artificial intelligence integration enhance the interpretation of data and facilitate informed clinical decision-making.
Participants will learn about NGS principles, clinical uses, and its implications in precision oncology. This session highlights how next-generation sequencing is transforming cancer research and patient care by offering a powerful tool for early detection, personalized treatment, and continuous disease monitoring, ultimately enhancing patient outcomes and changing the future of oncology.
Welcome to the Cancer and Oncology Conference 2026, where global researchers, clinicians, and academics meet to share advances in cancer biology, precision medicine, diagnostics, therapies, and global solutions for patient care.
